On January 12, 2026, Zacks Research Daily featured research reports on 16 major stocks, including Microsoft Corp. (MSFT), Eli Lilly and Co. (LLY), and Lam Research Corp. (LRCX), as well as a micro-cap stock Ampco-Pittsburgh Corp. (AP). Microsoft shows strong fundamentals with anticipated growth in net sales for fiscal 2026. Eli Lilly’s new drugs are driving sales growth despite competitive challenges. Lam Research benefits from advanced technology, but faces trade tensions. Ampco-Pittsburgh presents a mixed investment case with market capitalization of $105.09 million.

Microsoft’s shares have outperformed the Zacks Computer – Software industry in the past year. Eli Lilly’s GLP-1 drugs drive sales growth, with new drugs contributing as well. Lam Research benefits from 3D DRAM and advanced packaging technologies, but faces challenges in mature nodes spending. Ampco-Pittsburgh sees growth opportunities in U.S. energy security and nuclear infrastructure.

Featured reports also include Marsh & McLennan Companies, Inc. (MMC), Ross Stores, Inc. (ROST), and Cardinal Health, Inc. (CAH). Marsh and McLennan benefits from strategic acquisitions, while Ross Stores sees growth in merchandising. Cardinal Health drives growth through specialty pharma despite headwinds. Additionally, the article highlights other companies such as Acuity Brands, Inc. (AYI) and AutoNation, Inc. (AN) and their respective opportunities and challenges in the market.

The Zacks Equity Research department, led by Sheraz Mian, offers expert analysis and insights into aggregate earnings trends and previews. The research highlights investment opportunities in various sectors, including aerospace, healthcare, and technology. For more information on these stock recommendations and to access the full research reports, visit the Zacks Investment Research website.

Read more at Nasdaq: Top Stock Reports for Microsoft, Eli Lilly & Lam Research